(All times are in Central Standard Time)
|
|
|
Ancillary Educational Events
(In-person only, not available for online or virtual viewing)
|
8:00 – 9:15 am |
Lillly Advocate Program
Location: Room 220
|
9:30 – 10:45 am |
ABC Global Alliance Ten Year Breast Cancer Report The Do's & Don'ts of Communication on Advanced/Metastatic Breast Cancer
Location: Room 221ABC
|
|
SABCS Program Begins
|
11:00 am – 12:30 pm |
Career Development Workshop - Real World Research: Building Your Community
Location: TBD
Keynote: Clifford Hudis, MD, CEO of American Society of Clinical Oncology, Alexandria, Virginia
Topics: TBD
|
11:00 am – 12:30 pm |
Special Session 1: Open Bar and All You Can Eat? The Impact of Lifestyle in Breast Cancer Risk and Recurrence
Location: Stars at Night 1 & 2
Moderator: Seema Khan, MD, MS, Northwestern University Feinberg School of Medicine, Chicago
11:00 AM -11:25 AM - Topic 1: Genetics of alcohol metabolism and breast cancer risk
- Speaker: Julia Palmer, ScD, Boston University, Boston
11:25 AM -11:55 AM - Topic 2: Effects of alcohol consumption and cessation on breast cancer risk
- Speaker: Mary Beth Terry, PhD, Columbia University, New York
11:55 AM-12:15 PM - Topic 3: Obesity and Breast Cancer- the molecular link
- Speaker: Kristy Brown, PhD, University of Kansas Medical Center, Kansas City, Kansas
Patient Advocate: Stacey Tinianov, MPH, BCPA, Advocates for Collaborative Education, Santa Cruz, California
12:15 PM-12:30 PM Panel Q&A
|
11:00 am – 12:30 pm |
Special Session 2: Lobular Breast Cancer Updates
Location: Stars at Night 3 & 4
11:00 AM – 11:10 Moderator Introduction: Steffi Oesterreich, PhD, UPMC Hillman Cancer Center, Pittsburgh & Marleen Kok, MD, PhD, Netherlands Cancer Institute, Amsterdam
11:10 AM – 11:25 Topic 1: Current updates on diagnostic criteria and classification of special subtypes
- Speaker: Anne Vincent-Salomon, PhD, Institut Curie, Paris
11:25 AM – 11:40 AM Topic 2: Novel biomarkers with clinical implications
- Speaker: Christos Sotiriou, MD, PhD, Institut Jules Bordet, Anderlecht, Belgium
11:40 AM – 11:55 AM Topic 3: Controversies in clinical decision making – is there still a role for chemotherapy?
- Speaker: Otto Metzger, MD, Dana-Farber Cancer Institute, Boston
11:55 AM – 12:10 PM Topic 4: ILC-specific trials: lessons learned and future designs
- Speaker: Philipe Aftimos, MD, Insitut Jules Bordet, Anderlecht, Belgium
12:10 PM – 12: 30 PM Panel discussion
Patient Advocate: Flora Migyanka, BA, Seattle Genetics
|
11:00 am – 12:30 pm |
Special Session 3: Breast Cancer in Young Women: Biology, Treatment, and Ethics
Location: TBD
Moderator: Ann Partridge, MD, MPH, Dana-Farber Cancer Institute, Boston
Topic 1: Epidemiology and Biology of Young Onset Breast Cancer
- Speaker: Virginia Borges, MD, UCHealth Diane O’Connor Thompson Breast Center – Anschutz Medical Campus, Aurora, Colorado
Topic 2: Special Management Considerations for Young Patients with Breast Cancer
- Speaker: Yara Abdou, MD, MSCR, UNC Lineberger Comprehensive Cancer Center, Chappel Hill, North Carolina
Topic 3: Ethical Issues in the Care of Young Patients with Breast Cancer
|
12:45 – 2:15 pm |
Translational Workshop 1: Spatial Omics for Prediction, Prognostication, and Mechanistic Insights
Location: Hemisfair Ballroom 1-2
Moderator: Leif Ellisen, MD, PhD, Harvard University, Cambridge, Massachusetts
12:45 PM – 1:10 PM Topic 1: Proteomics
- Speaker: Sandro Santagata, MD, PhD, Harvard Medical School, Cambridge, Massachusetts
1:10 PM – 1:35 PM Topic 2: Metabolomics+
- Speaker: Ralph Deberardinis, MD, PhD, UT Southwestern, Dallas
1:35 PM – 2:00 PM Topic 3: Gylcocomics
2:00 PM – 2:15 PM Panel discussion
Patient advocate: Jane Perlmutter, PhD, MBA
|
12:45 – 2:15 pm |
Translational Workshop 2: Liquid Biopsy in Breast Cancer, Bridging Technology and Clinical Practice
Location: Stars at Night 1-2
Moderator: Pedram Razavi, MD, PhD, Memorial Sloan Kettering Cancer Center, New York
12:45 PM – 1:10 PM Topic 1: Emerging technologies in liquid biopsy, Maximilian Diehn, MD, PhD, Stanford University, Stanford, California
1:10 PM – 1:35 PM Topic 2: Expanding clinical application of liquid biopsy in breast cancer, Pedram Razavi, MD, PhD, Memorial Sloan Kettering Cancer Center, New York
1:35 PM - 2:00 PM Topic 3:
2:00 PM - 2:15 PM Panel discussion
Patient advocate: Judy Fitzgerald
|
12:45 – 2:15 pm |
Clinical Workshop 1: Risk Assessment and Management in Young Women
Location: Stars at Night 3-4
12:45 PM – 12:55 PM Moderator Introduction: Sonya Reid, MD, MPH, Vanderbilt-Ingram Cancer Center, Nashville
12:55 PM – 1:10 PM Topic 1:
1:10 PM – 1:25 PM Topic 2: Novel imaging strategies for young women – looking to the future
-
- Emily Conant, MD, University of Pennsylvania Perelman School of Medicine, Philadelphia
1:25 PM – 1:40 PM Topic 3:
1:40 PM – 1:55 PM Topic 4:
1:55 PM – 2:15 PM Panel discussion
Patient Advocate: Vernal Branch, Independent Research Patient Advocatie, Richmond, Virginia
|
2:30 – 4:15 pm |
Educational Session 1: After CDK4/6 Inhibitors: Advancing Treatment for HR+HER2-negative Metastatic Breast Cancer
Location: Stars at night 1-2
Moderator: Antoinette Tan, MD, MHS, Wake Forest University School of Medicine, Charlotte, North Carolina
2:30 PM – 3:00 PM Topic 1: Treatment Strategies after CDK4/6 Inhibitor Progression
-
- Speaker: Mafalda Oliveira, MD, PhD, Vall d'Hebron Hospital, Barcelona
3:00 PM – 3:30 PM Topic 2: Next Generation Endocrine Agents
-
- Speaker: Erica Mayer, MD, MPH, Dana-Farber Cancer Institute, Boston
3:30 PM – 4:00 PM Topic 3: Emerging Agents to Overcome CDK4/6 Inhibitor Resistance
-
- Speaker Shom Goel, PhD, FRACP, Peter MacCallum Cancer Centre, Melbourne, Australia
4:00 PM - 4:15 PM Panel Q&A
Patient Advocate: Abigail Johnston, SurvivingBreastCancer.org, Orlando, Florida
|
2:30 – 4:15 pm |
Educational Session 2: Dormancy and Re-activation of Breast Cancer Cells at Distant Metastatic Sites
Location: 221 ABC
Moderator: Heide Ford, PhD, University of Colorado School of Medicine, Denver
2:30 PM-3:00 PM - Topic 1: Viral reactivation of dormant breast cancer
-
- Speaker: Mercedes Rincon, PhD, University of Colorado School of Medicine, Aurora, Colorado
3:00 PM-3:30 PM Topic 2: Role of alveolar macrophages in dormancy
-
- Speaker: Xue-Yan He, PhD, Washington University in St. Louis
3:30 PM - 4:00 PM Topic 3: In vivo mechanisms regulating cellular dormancy and tumor recurrence
-
- Speaker: Lewis Chodosh, PhD, University of Pennsylvania Perelman School of Medicine, Philadelphia
- 4:00 PM - 4:15 PM Panel Q&A
4:00 PM - 4:15 PM Panel Discussion
Patient Advocate: Lynda Weatherby, Metastatic Breast Cancer Alliance, Seattle
|
2:30 – 4:15 pm |
Educational Session 3: Refining Local Therapy in Multi-disciplinary Care
Location: Stars at Night 3-4
Moderator: Jonathan Strauss, MD, MBA, Roberts H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
2:30 PM-3:00 PM Topic 1: Repeat Breast Conservation with reirradiation – what’s the data and how do we do it?
-
- Speaker: Chelain Goodman, MD, PhD, MD Anderson Cancer Center, Houston
3:00 PM-3:30 PM Topic 2: Should we irradiate the IM Nodes: Settling the Issue
-
- Speaker: Birgitte Offersen, MD, Aarhus University Department of Oncology, Aarhus, Denmark
3:30 PM - 4:00 PM Topic 3: The Truth About Radiotherapy and Reconstruction
-
- Speaker: Justin Broyles, MD, Brigham and Women’s Hospital, Boston
4:00 PM - 4:15 PM Panel Q&A
Patient Advocate: Judy Fitzgerald, Sisters4Prevention, Delray Beach, Florida
|
2:30 – 4:15 pm |
Educational Session 4: Balancing Act: Hormone Replacement Therapy in Breast Cancer Care
Location: Hemisfair Ballroom 1-2
Moderator: Tara Sanft, MD, Yale School of Medicine, New Haven, Connecticut
2:30 PM - 3:00 PM Topic 1: "HRT and Breast Cancer: How History Shaped Fear and What Comes Next" Re-examining past research, debunking myths, and guiding future recommendations
-
- Speaker: Maryam Lustberg, MD, MPH, Yale School of Medicine, New Haven, Connecticut
3:00 PM - 3:30 PM Topic 2: "Navigating the Latest HRT Guidelines: What Leading Medical Societies Say" A comprehensive review of updated recommendations from major health organizations.
-
- Speaker: Juliana Kling, MD, MPH, MACP, MSCP, Mayo Clinic, Phoenix
3:30 PM - 4:00 PM Topic 3: "HRT Across the Breast Cancer Spectrum: Risks, Benefits, and Considerations" Exploring HRT use in high-risk individuals, survivors, and different breast cancer subtypes.
-
- Speaker: Lisa Larkin, MD, FACP, MSCP, Ms. Medicine/HERmedicine, Cincinnati, Ohio
4:00 PM - 4:15 PM Panel Q&A
Patient Advocate: Thelma Perry Brown, BS, Patient Research Advocate, Birmingham, Alabama
|
2:30 – 4:15 pm |
Educational Session 5: Best of AACR
Location: Hemisfair Ballroom 3
2:30 PM – 3:00 PM Topic 1:
3:00 PM – 3:30 PM Topic 2:
3:30 PM – 4:00 PM Topic 3:
|
4:30 – 5:30 pm |
Late Breaking Abstracts
Location: Stars at Night 1-2
8-minute abstract presentations
|
5:15 – 5:45 pm |
Refreshment Break and Networking
Location: TBD
|
5:45 – 6:45 pm |
Clinical Trial Updates
Location: Stars at Night 1-2
8-minute abstract presentations
|